The team at HULAFE has been busy, presenting the SurPass to survivors and general clinicians at face-to-face and hybrid meetings at Hospital La Fe, Valencia, Spain. The aim of the meetings was to highlight the importance of long-term follow-up care, and how the SurPass can support better care. HULAFE will implement the SurPass in the PanCareSurPass Multi-Country Implementation Study, launching in 2023.
On 22 October 2022, Dr. Julia Balaguer presented ‘PanCareSurPass – Implementación digital del Pasaporte del Superviviente de cáncer infantil’ to survivors and general clinicians.
Then, on 13 December 2022, she delivered a hybrid course on long-term follow-up in childhood cancer survivors for general clinicians and other health professionals.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899999. The material presented and views expressed here are the responsibilities of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.